Creative Biolabs provides phage display-based protein interaction mapping services to identify binding partners, define interaction domains, uncover binding motifs, and analyze complex interactomes for target discovery and mechanism studies.
Explore Specialized Solutions for Different Needs
Within our Target Discovery & Validation portfolio, Creative Biolabs provides phage display protein interaction mapping services for partner discovery, interaction domain analysis, binding motif identification, and interactome studies.
Designed for projects with different target types, biological contexts, and mapping goals, this service supports both broad interaction discovery and more focused analysis across purified proteins, cell-based targets, extracellular systems, and other biologically relevant screening settings. Whether you are investigating unknown partners, defining binding regions, or refining a mechanism-focused study, we can help translate your research question into a practical screening route from the start.
This service can support projects involving:
Protein interaction mapping often requires more than a fixed screening format. Different projects bring different demands in target presentation, library design, counter-screening logic, and downstream analytical depth. Creative Biolabs addresses these variables through established platforms, flexible design, and research-oriented reporting.
Supports partner discovery, domain mapping, motif analysis, and complex interactome studies.
Matches library type and screening strategy precisely to your target properties and study goals.
Supports protein-based, cell-based, ex vivo, and in vivo discovery routes seamlessly.
Provides fully interpretable results along with practical, data-driven next-step recommendations.
If your project involves a challenging target or a less conventional biological context, you can discuss the study goal with our team before confirming the screening route.
Explore our comprehensive suite of interaction mapping services tailored to uncover complex biological networks.
Our service supports identification of previously unrecognized binding partners for target discovery and pathway exploration.
Helps define the regions responsible for binding and clarify domain-level interaction architecture.
Supports identification of short recognition elements and enriched sequence patterns associated with interaction specificity.
Supports analysis of interaction landscapes between viral factors and host systems in mechanism-oriented research.
Supports receptor deorphanization and ligand discovery in studies where membrane context and native presentation are important.
Supports identification of substrate candidates involved in ubiquitination and deubiquitination research.
Supports interaction studies involving adhesion, signaling, tissue remodeling, and cell communication.
Supports co-factor identification for transcriptional regulators and related gene regulation studies.
We also provide highly customized phage display solutions tailored to your unique targets and screening contexts. Contact our experts to discuss your specific project details.
Consult an ExpertChoosing the Right Screening Platform for Different Project Needs
Different protein interaction mapping studies place different demands on target presentation, screening pressure, and biological relevance. Platform selection is guided by the biological question, target format, and intended downstream use. Creative Biolabs can help determine an appropriate platform entry point and downstream path based on your target format, interaction question, and research objective.
This route is suitable for purified proteins, domains, enzymes, ectodomains, or defined complexes. It supports biochemical specificity assessment, interaction domain mapping, binding motif studies, and refined counter-screening design.
This route is suitable for membrane proteins, orphan receptors, and targets whose interaction behavior depends on native conformation. It supports more physiologically relevant interaction mapping in cell-associated systems.
This route is suitable for studies in which tissue architecture and microenvironmental context are important. It is especially useful for extracellular matrix, cell-surface, and tissue-selective interaction research.
This route is suitable for projects in which biodistribution, physiological clearance, or barrier crossing may affect discovery outcomes. It can provide higher biological relevance for selected interaction studies.
If your study already has defined inputs or a clear interaction hypothesis, Creative Biolabs can help turn that information into a more focused screening workflow.
Define biological question, target type, mapping goal, and screening context
Select suitable phage display libraries and screening strategy
Perform biopanning and enrichment under project-matched conditions
Analyze enriched hits for motifs, domains, and interaction patterns
Deliver results, interpretation, and next-step recommendations
Candidate binders or interaction hits identified through screening.
Domain-level or motif-level interaction mapping results.
Sequence clustering, enrichment analysis, and hit prioritization.
Data summary, result interpretation, and next-step recommendations.
Purified proteins, protein domains, peptides, or target-expressing cells.
Relevant cell models, pathway background, or system-specific information.
Partner discovery, domain mapping, motif identification, interactome hypothesis.
Preferred screening context, counter-screening needs, or downstream plans.
Because these research areas differ in target presentation and discovery constraints, our platform supports tailored study routes rather than a single fixed workflow.
Identification of new interaction partners and candidate targets
Interaction mapping in pathway regulation and receptor signaling
Analysis of virus-host and related biological interaction systems
Ligand discovery and receptor-context interaction studies
Discovery of interaction candidates linked to modification pathways
ECM, cell-surface, and tissue-associated interaction mapping
Discovery of co-factors and regulator-associated binding partners
Tell us your target type, interaction question, preferred screening context, and downstream goal. Creative Biolabs can help translate these inputs into a practical phage display workflow.
Discuss Your Project DetailsPublished studies provide useful examples of how phage display can be applied in interaction-focused research. Based on this type of published technical logic, Creative Biolabs supports researchers with clearer experimental planning and screening design for research use.
Fig. 1. Schematic Representation of Protein–Peptide Interaction Identification Protocol.1,4
This study presents a protein–peptide interaction identification protocol that integrates phage biopanning, next-generation sequencing, and bioinformatic analysis into a connected experimental workflow. Rather than treating phage selection as a standalone enrichment step, the authors extend the process through library preparation, sequencing, and sequence-level interpretation, enabling more systematic identification of peptide binders.
In this paper, the workflow is applied to the identification of immunologically relevant epitopes of the wasp venom allergen Ves v 5, showing how experimental screening can be linked with downstream motif discovery, peptide clustering, and structural mapping.
Fig. 2. On-Phage Binding Region Binning Against IL-23 Alanine Variants.2,4
This study provides a clear example of binding-region binning using an integrated phage and yeast display workflow. The authors displayed wild-type IL-23 and alanine variants on yeast, then used flow cytometry to compare how peptide-phage bound across these target variants. Rather than serving only for broad hit discovery, phage display was used here to distinguish peptide groups by likely binding region while the peptides remained on-phage.
In Figure 2, this strategy differentiates Fab-phage from FGL-motif peptide-phage and shows that the FGL peptides retain binding to most IL-23 variants but lose or reduce binding to specific mutants, especially Ala26/W26A and, to a lesser extent, Ala24/L24A. These data support region-level binning before peptide synthesis, while later HDX-MS and crystallographic analyses were used to confirm the binding region assignments.
Fig. 3. N3 Peptide Binding to Trypomastigotes.3,4
This study supports the application of phage display to binder discovery against targets presented in a native parasite-surface context. The authors identified the N3 peptide through selection on Trypanosoma cruzi trypomastigotes and showed preferential binding to infective parasite forms, together with reduced infection of Vero cells in follow-up assays.
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
